Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY1 | P47900 | 7/20 | 0.84 |
| ▸ | P2RY2 | P41231 | 4/20 | 0.84 |
| ▸ | P2RX1 | P51575 | 4/20 | 0.84 |
| ▸ | P2RX3 | P56373 | 4/20 | 0.84 |
| ▸ | SRC | P12931 | 2/20 | 0.84 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.84 |
| ▸ | P2RX2 | Q9UBL9 | 2/20 | 0.84 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.84 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.84 |
| ▸ | TRPM2 | O94759 | 2/20 | 0.80 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.80 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.80 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.80 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.80 |
| ▸ | LDHA | P00338 | 1/20 | 0.80 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.80 |
| ▸ | FBP1 | P09467 | 1/20 | 0.80 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.80 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.80 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.80 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1746647 | 1.00 | P2RY1 (0.84) | P2RY1P2RY2P2RX1P2RX3SRC | |
| SCHEMBL459771 | 1.00 | P2RY1 (0.84) | P2RY1P2RY2P2RX1P2RX3SRC | |
| SCHEMBL10396861 | 0.99 | P2RY1 (0.86) | P2RY1P2RY2P2RX1P2RX3SRC | |
| Water SCHEMBL9225179 | 0.99 | P2RY1 (0.82) | P2RY1P2RY2P2RX1P2RX3SRC | |
| SCHEMBL3792441 | 0.99 | P2RY1 (0.82) | P2RY1P2RY2P2RX1P2RX3SRC | |
| SCHEMBL5838786 | 0.99 | P2RY1 (0.82) | P2RY1P2RY2P2RX1P2RX3SRC | |
| SCHEMBL28646263 | 0.98 | P2RY1 (0.84) | P2RY1P2RY2P2RX1P2RX3SRC | |
| SCHEMBL28367704 | 0.98 | P2RY1 (0.84) | P2RY1P2RY2P2RX1P2RX3SRC | |
| SCHEMBL6242721 | 0.98 | P2RY1 (0.84) | P2RY1P2RY2P2RX1P2RX3SRC | |
| SCHEMBL27962220 | 0.97 | P2RY1 (0.80) | P2RY1P2RY2P2RX1P2RX3SRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 186 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112881311-B | Creatine kinase detection reagent, kit and detection method | 深圳迈瑞生物医疗电子股份有限公司 | 2025-05-30 | — | — | CN | claimed |
| CN-114480567-B | Anti-heparin interference creatine kinase biochemical detection reagent | 天津中成佳益生物科技有限公司 | 2024-01-26 | — | — | CN | claimed |
| EP-4240339-A1 | COMPOSITIONS AND METHODS TO PROMOTE THYMIC FUNCTION | Fred Hutchinson Cancer Center (US) | 2023-09-13 | — | — | EP | claimed |
| US-20230263800-A1 | COMPOSITIONS AND METHODS TO PROMOTE THYMIC FUNCTION | FRED HUTCHINSON CANCER CENTER (US) | 2023-08-24 | — | — | US | claimed |
| CN-115558703-A | Creatine kinase detection kit for resisting lipidemia interference and preparation method thereof | 青岛汉唐生物科技有限公司 | 2023-01-03 | — | — | CN | claimed |
| CN-114721457-A | Low-temperature coefficient resistance-free band gap reference source | 浙江大学 | 2022-07-08 | — | — | CN | claimed |
| WO-2022098776-A1 | COMPOSITIONS AND METHODS TO PROMOTE THYMIC FUNCTION | FRED HUTCHINSON CANCER RESEARCH CENTER (US) | 2022-05-12 | — | — | WO | claimed |
| CN-112539696-B | Depolarization compensation method for prism of self-reference interferometer | 中国科学院微电子研究所 | 2022-04-29 | — | — | CN | claimed |
| CN-112881311-A | Creatine kinase detection reagent, kit and detection method | 深圳迈瑞生物医疗电子股份有限公司 | 2021-06-01 | — | — | CN | claimed |
| US-8608922-B2 | Biosensor for continuous monitoring of metabolites and proteins and methods of manufacture thereof | THE UNIVERSITY OF CONNECTICUT (US) | 2013-12-17 | — | — | US | claimed |
| US-20040135997-A1 | Metal coated nanocrystalline silicon as an active surface enhanced raman spectroscopy (SERS) substrate | INTEL CORPORATION | 2004-07-15 | — | — | US | claimed |
| EP-0969848-A1 | USE OF DIADENOSINE POLYPHOSPHATES FOR REDUCING BLOOD PRESSURE | Clemson University (US) | 2000-01-12 | — | — | EP | claimed |
| WO-1998030222-A1 | USE OF DIADENOSINE POLYPHOSPHATES FOR REDUCING BLOOD PRESSURE | CLEMSON UNIVERSITY (US) | 1998-07-16 | — | — | WO | claimed |
| EP-0721986-A2 | Creatine kinase reagent | WAKO PURE CHEMICAL INDUSTRIES LTD (JP) | 1996-07-17 | — | — | EP | claimed |
| US-5009994-A | Uniform distribution | EM DIAGNOSTIC SYSTEMS, INC. (US) | 1991-04-23 | — | — | US | claimed |
| US-4810639-A | CREATINE KINASE ISOENZYMES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1989-03-07 | — | — | US | claimed |
| EP-0227440-A2 | Immunoassay for creatine kinase MB using bound and soluble antibodies | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-07-01 | — | — | EP | claimed |
| EP-0015437-B1 | METHOD AND REAGENT FOR THE DETERMINATION OF CREATINE KINASE | Roche Diagnostics GmbH (DE) | 1981-11-25 | — | — | EP | claimed |
| EP-0008341-B1 | METHOD AND REAGENT FOR ENZYMATIC DETERMINATIONS AND TEST KIT FOR THIS METHOD | Roche Diagnostics GmbH (DE) | 1981-11-04 | — | — | EP | claimed |
| US-4286057-A | QUANTITATIVE ANALYSIS OF CREATINE KINASE USING THE LUMINESCENT SYSTEM OF THE FIREFLY | BOEHRINGER MANNHEIM GMBH (DE) | 1981-08-25 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230263800-A1 | COMPOSITIONS AND METHODS TO PROMOTE THYMIC FUNCTION | BMP4, P2RY2, GPR39 | P2RY1 6/4885P2RY2 2/4885P2RX1 17/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.